Thermo Fisher Scientific Inc.
TMO | NYSE
$684.98
-$12.02 (-1.72%)
Nov 2, 2026, 1:18 PM ET · Market open
TTM Period Ending | Q3 2026 Sep 26, 2026 | Q2 2026 Jun 27, 2026 | Q1 2026 Mar 28, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 27, 2025 | Q2 2025 Jun 28, 2025 | Q1 2025 Mar 29, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 28, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jul 1, 2023 | Q1 2023 Apr 1, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Oct 1, 2022 | Q2 2022 Jul 2, 2022 | Q1 2022 Apr 2, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Oct 2, 2021 | Q2 2021 Jul 3, 2021 | Q1 2021 Apr 3, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 7.09B | 6.99B | 6.86B | 6.72B | 6.58B | 6.59B | 6.53B | 6.34B | 6.14B | 6.22B | 6.03B | 6B | 5.94B | 5.73B | 6.03B | 6.96B | 7.05B | 7.45B | 7.61B | 7.73B | 8.57B | 8.6B | 7.92B |
Depreciation & Amortization | 3.11B | 2.94B | 2.81B | 2.78B | 2.79B | 2.87B | 2.98B | 3.11B | 3.21B | 3.32B | 3.38B | 3.41B | 3.42B | 3.4B | 3.38B | 3.38B | 3.22B | 3.01B | 2.83B | 2.59B | 2.51B | 2.46B | 2.37B |
Stock-Based Compensation | 84M | 84M | 84M | 84M | n/a | 68M | 152M | 222M | 283M | 282M | 272M | 278M | 292M | 302M | 305M | 307M | 309M | 283M | 257M | 230M | 204M | 205M | 201M |
Other Working Capital | 446M | 2.64B | 802M | 489M | 742M | -1.38B | -869M | -231M | 443M | 404M | -98M | -844M | -611M | -969M | -1.1B | -442M | -1.65B | -1.05B | -322M | -768M | -851M | -358M | 510M |
Other Non-Cash Items | -819M | -3.14B | -1.65B | -1.62B | -1.58B | 573M | 534M | 385M | 394M | 396M | 437M | 560M | 502M | 563M | 472M | 550M | 1.04B | 863M | 950M | 957M | 522M | 642M | 542M |
Deferred Income Tax | -587M | -504M | -618M | -639M | -728M | -1B | -1.03B | -1.01B | -1.68B | -1.58B | -1.41B | -1.3B | -764M | -722M | -802M | -995M | -813M | -700M | -769M | -406M | -511M | -541M | -487M |
Change in Working Capital | 446M | 2.64B | 802M | 489M | 594M | -1.53B | -1.02B | -379M | 750M | 711M | 209M | -537M | -1.22B | -1.58B | -1.71B | -1.05B | -2.44B | -1.84B | -1.11B | -1.56B | -1.1B | -1.11B | -641M |
Operating Cash Flow | 9.32B | 9.01B | 8.29B | 7.82B | 7.65B | 7.58B | 8.14B | 8.67B | 9.1B | 9.35B | 8.93B | 8.41B | 8.17B | 7.69B | 7.68B | 9.15B | 8.36B | 9.07B | 9.77B | 9.54B | 10.19B | 10.25B | 9.91B |
Capital Expenditures | -1.73B | -1.7B | -1.54B | -1.53B | -1.54B | -1.41B | -1.42B | -1.4B | -1.33B | -1.39B | -1.37B | -1.48B | -1.62B | -1.84B | -2.06B | -2.24B | -2.52B | -2.5B | -2.54B | -2.52B | -2.28B | -2.12B | -1.85B |
Cash Acquisitions | -8.85B | -12.88B | -12.88B | -4B | -4.01B | -3.08B | -3.07B | -3.08B | -3.08B | -878M | -941M | -3.65B | -3.65B | -2.74B | -2.69B | -21M | -17.9B | -18B | -18.09B | -19.4B | -1.55B | -1.46B | -1.38B |
Purchase of Investments | -700M | -107M | -133M | -383M | -1.68B | -1.93B | -1.9B | -3.4B | -2.07B | -1.78B | -1.76B | -2M | -2M | -2M | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 1.56B | 1.82B | 1.86B | 1.61B | 2.07B | 1.91B | 1.91B | 1.97B | 203M | 111M | 64M | 2M | 2M | 2M | 2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.73B | 837M | 213M | 249M | 243M | 140M | 137M | 57M | 31M | 90M | -27M | -14M | -13M | -72M | 115M | 105M | 101M | 102M | 23M | -14M | -34M | -35M | -22M |
Investing Cash Flow | -7.98B | -12.03B | -12.48B | -4.05B | -4.92B | -4.37B | -4.34B | -5.84B | -6.24B | -3.84B | -4.03B | -5.14B | -5.29B | -4.66B | -4.63B | -2.16B | -20.33B | -20.4B | -20.6B | -21.93B | -3.87B | -3.62B | -3.25B |
Debt Repayment | 3.89B | 3B | 2.21B | n/a | -3.29B | -2.39B | -1.61B | -2.4B | -1.21B | 1.87B | 546M | -155M | 4.64B | 2.67B | 2.17B | 654M | 5.76B | 8.88B | 10.71B | 8.91B | 315M | -3.52B | -2.3B |
Common Stock Repurchased | -7B | -5B | -4B | -3B | -1B | -3B | -3B | -4B | -3B | -3B | -3B | -3B | -4B | -4B | -4B | -3B | -2.1B | -2.1B | -2.1B | -2.1B | -2.03B | -2.03B | -2.03B |
Dividend Paid | -673M | -662M | -649M | -636M | -623M | -610M | -597M | -583M | -570M | -555M | -541M | -523M | -504M | -487M | -469M | -455M | -441M | -425M | -411M | -395M | -379M | -364M | -348M |
Other Financial Acitivies | 4.77B | 4.08B | 5.43B | 5.44B | -483M | 53M | 131M | 195M | 226M | 177M | 145M | 56M | 119M | 63M | 47M | -7M | -165M | -134M | -146M | -72M | 8M | -10M | -9M |
Financial Cash Flow | 985M | 1.42B | 3B | 1.8B | -5.39B | -5.95B | -5.07B | -6.79B | -4.55B | -1.51B | -2.85B | -3.62B | 197M | -1.81B | -2.26B | -2.81B | 3.27B | 6.46B | 8.29B | 6.58B | -1.94B | -5.77B | -4.51B |
Net Cash Flow | 2.48B | -1.51B | -892M | 5.84B | -2.66B | -2.5B | -1.35B | -4.06B | -1.5B | 3.95B | 2.02B | -440M | 3.23B | 1.25B | 721M | 4.05B | -9.11B | -5.13B | -2.82B | -5.85B | 4.48B | 1.2B | 2.59B |
Free Cash Flow | 7.6B | 7.32B | 6.75B | 6.29B | 6.11B | 6.17B | 6.72B | 7.27B | 7.78B | 7.96B | 7.56B | 6.93B | 6.55B | 5.85B | 5.62B | 6.91B | 5.83B | 6.57B | 7.23B | 7.02B | 7.92B | 8.13B | 8.06B |
Adj. Free Cash Flow | 7.51B | 7.23B | 6.66B | 6.21B | 6.11B | 6.1B | 6.57B | 7.05B | 7.49B | 7.68B | 7.29B | 6.65B | 6.25B | 5.55B | 5.32B | 6.6B | 5.52B | 6.28B | 6.98B | 6.79B | 7.71B | 7.93B | 7.86B |
Maintenance CapEx | -1.53B | -1.37B | -1.14B | -1.12B | -1.22B | -1.2B | -1.29B | -1.28B | -1.32B | -1.39B | -1.37B | -1.48B | -1.47B | -1.39B | -1.26B | -1.03B | -1.44B | -1.54B | -1.47B | -1.24B | -435.62M | -72.24M | -161.32M |
Growth CapEx | -196.54M | -322.13M | -397.15M | -401.7M | -324.01M | -204.02M | -129M | -124.45M | -5.6M | n/a | n/a | n/a | -158.97M | -445.25M | -805.91M | -1.21B | -1.08B | -957.82M | -1.06B | -1.29B | -1.84B | -2.05B | -1.69B |
Owner Earnings | 7.79B | 7.64B | 7.15B | 6.69B | 6.44B | 6.37B | 6.85B | 7.39B | 7.78B | 7.96B | 7.56B | 6.93B | 6.7B | 6.3B | 6.43B | 8.12B | 6.91B | 7.52B | 8.3B | 8.31B | 9.76B | 10.18B | 9.75B |
Add to Watchlist
Select watchlists to add or remove TMO